[The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations].
D000873:Anthracenes / Q000627:therapeutic use*; D001706:Biopsy; D002952:Citric Acid Cycle; D004798:Enzymes / Q000378:metabolism; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006019:Glycolysis; D006651:Histocytochemistry; D006801:Humans; D008264:Macrophages; D008407:Mast Cells; D009249:NADP; D010428:Pentosephosphates; D010734:Phosphogluconate Dehydrogenase / Q000378:metabolism; D011565:Psoriasis / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D012867:Skin / Q000201:enzymology / Q000473:pathology
D000873:Anthracenes; D004798:Enzymes; D010428:Pentosephosphates; D009249:NADP; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase
Uber die Wirking von Dithranol (Cignolin) bei Psoriasis vulgaris. Cyto- und histochemische Untersuchungen.